The Result of the General Meeting held on 20 April 2012 are available in the Investor Relations section.
Click to Read
Our recently updated Seglin section provides more information about this innovative drug discovery platform.
Seglin™ Technology
Visit our programmes section to find out more about our research activities and drug programmes.
Drug Programmes